Breast hyperplasia
Fibrocystic breast disease is the most common breast disease in women, and its incidence ranks first among breast diseases. In recent years, the incidence of the disease has been increasing year by year, and the age of onset is getting younger and younger. Fibrocystic breast disease is the physiological proliferation and incomplete restoration of normal breast lobules, and the normal structure of the breast is disordered. It is a pathological hyperplasia. It is neither an inflammatory nor a tumor disease. It is more common in women aged 30-50, with the peak incidence at 35-40 years old.
-
Site of disease:
breast -
Infectious :
Not contagious -
Frequent population:
Women aged 30-50 -
Related symptoms:
Breast pain nodule cyst premenstrual breast pain axillary pain -
Concurrent disease:
Related Drugs
Rukang Capsules
Manufacturer:
China Resources Sanjiu (Tangshan) Pharmaceutical Co., Ltd.
Rupishu Tablets
Manufacturer:
Jiangxi Kang'enbei Tianshikang Pharmaceutical Co., Ltd.
Prunella Vulgaris Granules
Manufacturer:
Jiangsu Morning Brand Pharmaceutical Group Co., Ltd.
Small gold capsule
Manufacturer:
Jianmin Pharmaceutical Group Co., Ltd.
Rujiling Capsules
Manufacturer:
Hebei Gogin Pharmaceutical Co., Ltd.
Rujiling Capsules
Manufacturer:
Sichuan QILI Pharmaceutical Co., Ltd.
Breast mass elimination tablets
Manufacturer:
Xi'an Beilin Pharmaceutical Co., Ltd.
Desheng Capsules
Manufacturer:
Shaanxi Dongtai Pharmaceutical Co., Ltd.
Desheng Capsules
Manufacturer:
Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
Ruan Tablets
Manufacturer:
Ankang Chia Tai Pharmacetucial Co., Ltd.
Related Ingredients
-
D(+)-Trehalose dihydrate list
6138-23-4 -
MYRRH GUM list
9000-45-7 -
OLIBANUM GUM list
8050-07-5 -
Maltitol list
585-88-6 -
Riligustilide list
89354-45-0